The Board of Queensland Bauxite (ASX:QBL) is pleased to announce a materially positive update regarding the company's research into the use of medical cannabis in autoimmune disease treatment.
Queensland Bauxite Ltd (ASX:QBL) provides the Company's Quarterly Report.
Further to the Transformation Announcement made on 20 June 2018, the Board of Queensland Bauxite Limited (ASX:QBL) has recognised that due to current market conditions, the intended capital raise at 8c is no longer an immediate practical option. As a result, the Board has decided to amend the raising price for the recompliance.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading medicinal cannabis company advises that THC's wholly owned subsidiary, Canndeo Limited, has released its first medicinal cannabis products, imported from the Company's European strategic alliance partner, Endoca.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading medicinal cannabis company and Biofloral Inc, a Canadian east coast hydroponics company, have chosen to work together to benefit from each other's IP and distribution networks. The proposed acquisition of BioFloral (ASX- 24 January 2018) is not proceeding.
MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) provides a summary of the outlook for each of its cannabis sector investments through to the end of this year.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company provides the enclosed Company Presentation updated to July 2018 in accordance with ASX Listing Rule 3.1.
